US Heart & Vascular

What US Heart & Vascular does

US Heart & Vascular (USHV) is a physician-led cardiovascular management services organization (MSO) headquartered in Franklin, Tennessee, formed in 2021. USHV partners with independent cardiology and cardiovascular practices under a five-step affiliation model (fit call, diligence, transition blueprint, transaction, 90-day integration), preserving physician governance and local brand identity while providing enterprise-level shared services. Its affiliated network comprises 15 multi-state practices with 300+ cardiovascular specialists operating across six states (Alabama, Arizona, Georgia, Kansas, Louisiana, Texas), serving well over two million patients annually. The company is backed by Ares Management's Private Equity Group and Rubicon Founders.

USHV's product surface comprises shared MSO services (revenue cycle management, payor contracting, HR and credentialing, group purchasing, ASC development, and capital for growth), a technology stack built on eClinicalWorks EMR and the proprietary CardiacIQ analytics platform (population health, risk coding, predictive insights), and patient-facing programs (24/7 Call Us First Concierge Hotline, Remote Patient Monitoring, My HeartCare care management). AI-enabled patient engagement is delivered via integrated third-party platforms—Phreesia, Thesis Care AI agents, and Cedar—alongside the company's own analytics layer. The affiliated network includes a mix of long-tenured independent cardiology groups (HeartPlace, Heartland Cardiology, Pima Heart & Vascular, Birmingham Heart Clinic) and other regional practices.

USHV generates revenue primarily through MSO fees charged to affiliated practices for non-clinical management services. Revenue mechanics include recurring management fees tied to practice collections, plus exposure to value-based care economics through partnerships such as the Humana Medicare Advantage agreement, shared savings on specialty pharmacy (FillPoint Health, ENBUMYST via Corstasis Therapeutics), ASC EBITDA participation (e.g., the Lafayette, Louisiana AAAHC-accredited ASC), clinical research site revenue (Iterative Health), and group purchasing margin. The Humana, Iterative Health, Corstasis, and FillPoint partnerships in 2025–2026 reflect a deliberate move toward risk-bearing and specialty-product revenue streams alongside fee-for-service MSO income.

Name

US Heart & Vascular

Legal name

US Heart & Vascular

Website

https://usheartandvascular.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

US Heart & Vascular is a physician-led cardiovascular management services organization that partners with independent cardiology practices across the U.S., providing shared services, analytics, payor contracting, and value-based care infrastructure to 300+ specialists in 15 affiliated practices.

Ownership category

akta.pro rank

Product category

Cardiovascular Practice Management Services

NAICS

Offices of Physicians (62111), HMO Medical Centers (621491)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Management Consulting Services (8742), Services-Health Services (8000)

akta.pro primary industry

Value-Based Contracting Analytics (ACO/MSSP/MA, shared savings/risk) (HLACAHAA)

akta.pro secondary industries

General Cardiology (Consultative) (HLAKABAA), Heart Failure & Transplant Cardiology (HLAKABAD), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Single-Specialty PPO Networks (HLAEANAD)

Keywords

• Cardiovascular practice management
• Physician-led MSO services
• Value-based cardiology care
• Revenue cycle management
• Cardiology partnership platform

Headquarters

HQ city

Franklin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Management Services Organization (MSO) Fees: USHV provides non-clinical management solutions and resources to affiliated cardiovascular practices in exchange for fees. Services include revenue cycle management, HR, payor contracting, finance, accounting, analytics, recruiting, and patient journey ancillary services. The company operates as a physician-led management platform enabling independent cardiologists to expand patient access and improve outcomes while reducing costs to the healthcare system.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

US Heart & Vascular is a physician-led management services organization (MSO) that partners with independent cardiovascular and cardiology practices to provide non-clinical management infrastructure including revenue cycle management, payor contracting, HR, credentialing, analytics, recruiting, ASC development, and group purchasing, in exchange for MSO fees. The platform preserves local physician governance, brand identity, and clinical autonomy while delivering shared technology (eClinicalWorks EMR, CardiacIQ analytics), AI-enabled patient engagement tools, and capital for growth across a multi-state network.

Product overview

US Heart & Vascular operates as a physician-led cardiovascular practice management platform that unites independent cardiology and vascular groups under one shared services model. The platform combines the CardiacIQ data analytics platform (providing real-time population health insights and predictive analytics) with operational services including revenue cycle management, payor contracting, EHR (eClinicalWorks), credentialing, and HR support. Growth services include ASC development, group purchasing, and practice branding. Patient-facing services include 24/7 Call Us First concierge hotline, Remote Patient Monitoring programs, and My HeartCare care management programs. The company also integrates AI technologies (Phreesia, Thesis, Cedar) for patient engagement and clinical operations, serving over 200 cardiovascular specialists across 6 states.

Differentiator

Problem solved

Functional benefit

Brands

• CardiacIQ: Centralized analytics platform providing secure analytics, predictive insights, and population health tools for cardiovascular care.
• Call Us First Concierge Hotline
• My HeartCare

Products and services

• CardiacIQ Data Platform Centralized analytics platform that delivers population health tools, predictive insights, and risk coding accuracy with real-time visibility into clinical activity, performance, and cost for affiliated cardiovascular practices.
• 24/7 Call Us First Concierge Hotline 24/7 hotline staffed by virtual USHV cardiac nurses providing clinical guidance and care coordination to eligible patients outside clinic hours.
• Remote Patient Monitoring Program Connected-device program enabling patients to track blood pressure, medications, and follow-ups in real time, with clinical team oversight for heart failure and chronic cardiovascular conditions.
• My HeartCare Care Management Programs Care management programs covering post-hospital transitions, chronic care management, and integrated care clinics supporting value-based cardiology programs.
• eClinicalWorks EMR Platform Cloud-based electronic medical records system with 24/7 help desk and encrypted backup, deployed enterprise-wide as the shared clinical record across all USHV-affiliated practices.
• Revenue Cycle Management Centralized revenue cycle services including billing, coding reviews, denial management, and transparent monthly reporting delivered to each practice's governance board.
• Payor Contracting Services Payor contract strategy and negotiation services informed by comparative analytics to strengthen contracting outcomes across the USHV cardiovascular network.
• ASC Development Services Ambulatory Surgery Center development support including case selection, staffing models, and supply strategy enabling appropriate site-of-care shifts for cardiovascular procedures.
• Credentialing and HR Services Centralized credentialing, payroll, benefits, and HR compliance services delivered to affiliated physician practices.
• Group Purchasing Group purchasing power and supply chain management that reduces device and supply costs across the cardiovascular network.
• AI-enabled Patient Engagement Suite (Phreesia, Thesis, Cedar) Suite of AI-enabled patient engagement tools (Phreesia for intake/scheduling, Thesis for AI clinical operations, Cedar for patient payments) deployed across the network to streamline scheduling, communication, and payment experiences.

Quantifiable outcome

• Grown from 2 founding groups to 15 multi-state practices since 2021
• +3 more outcomes

Named customers8 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Five partnerships are on record, tiered strategic, core and minor.

• Iterative HealthstrategicStrategic or Co-development Partner · 2 April 2026Strategic partnership for community-based cardiovascular research. USHV research sites join Iterative Health's global site network spanning 100+ sites across three continents. USHV physicians gain access to cutting-edge clinical trials and therapies for their patients. Iterative Health provides end-to-end support across clinical research operations, business development, and technology innovation, expanding USHV's multispecialty research capabilities into cardiology.
• HumanacoreStrategic or Co-development Partner · 4 March 2026USHV and Humana formed a multi-state value-based care partnership covering Arizona, Texas, Florida, Georgia, and Louisiana, focused on improving cardiovascular outcomes for Medicare Advantage members. Key capabilities include a 24/7 Call Us First Concierge Hotline staffed by virtual cardiac nurses, remote patient monitoring, My HeartCare care management programs, and the CardiacIQ data platform providing analytics and population health tools.
• TMC Health / Tucson Medical CenterminorStrategic or Co-development Partner · 17 December 2025Co-sponsorship of the Arizona Valves 2026 Summit (formerly CVIS), a premier interventional cardiovascular conference in the Southwest. USHV serves as title sponsor alongside Pima Heart & Vascular and TMC Health, featuring live case broadcasts, hands-on innovation workshops, and clinical research day.
• FillPoint Health (Lyceum Health)coreStrategic or Co-development Partner · 23 October 2025Exclusive specialty pharmacy partnership in which FillPoint Health provides dispensing rights for RNAi therapies for rare, inherited disorders in cardiovascular disease. FillPoint handles prior authorizations, benefit navigation, patient onboarding, and real-time provider visibility and adherence tracking through its RxNexus platform. USHV physicians can focus on clinical care while ensuring patients receive uninterrupted access to therapies.
• Corstasis TherapeuticsstrategicStrategic or Co-development Partner · 18 September 2025Strategic collaboration to co-develop and pilot optimized value-based care pathways for ENBUMYST (bumetanide nasal spray) across USHV's network of affiliated cardiology practices. The partnership focuses on clinical workflows supporting timely decongestion while demonstrating reductions in ED visits, hospital admissions, and total cost of care for heart failure patients.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Cardiovascular Associates of America (CVAUSA): PE-backed (Webster Equity Partners) cardiology-only practice management platform consolidating independent cardiovascular groups across the U.S. Most direct functional and structural competitor to USHV's cardiology MSO model.
• One GI: PE-backed gastroenterology specialty MSO previously led by USHV CEO Robbie Allen, who drove it to ~$400M revenue. Closest analogous specialty-MSO playbook, validating the model USHV is replicating in cardiology.
• U.S. Anesthesia Partners (USAP): PE-backed single-specialty (anesthesia) MSO aggregating independent anesthesia groups. Closest structural analog to USHV outside cardiology — both face similar PE-backed MSO consolidation and CPOM regulatory dynamics.
• GI Alliance: Largest PE-backed gastroenterology specialty MSO in the U.S. Comparable specialty-MSO business model, payor contracting leverage strategy, and ASC development orientation to USHV.
• Allied Digestive Health: PE-backed gastroenterology MSO consolidating independent GI practices in the Northeast/Mid-Atlantic. Same specialty-MSO playbook (non-clinical management services, clinical autonomy, payor leverage) as USHV, just in a different specialty.

Emerging players

• CardioOne: Cardiology-focused practice management and VBC enablement platform serving independent cardiology groups. Competes for the same affiliate pipeline as USHV but at an earlier stage of scale.
• Wellvana Health: VBC enablement platform partnering with primary care and cardiology groups on risk-bearing contracts. Comparable MA VBC enablement model to USHV, particularly around Humana and other MA payor relationships, though smaller in scale and specialty breadth.

Broad incumbents

• Privia Health: Public, multi-specialty physician practice management and VBC platform. Competes with USHV for independent physician groups and offers similar value-based care infrastructure, but at much larger scale and across multiple specialties.
• agilon health: Public value-based primary care platform partnering with payors on full-risk MA contracts. Comparable VBC economics and MA-focused model to USHV's Humana partnership, but anchored in primary care rather than cardiology.
• Astrana Health (formerly Apollo Medical Holdings): Public value-based care delivery and physician network platform with strong MA exposure. Overlapping VBC contracting, risk-bearing infrastructure, and physician network aggregation strategy with USHV, but broader in scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/us-heart-and-vascular
• Facebookfacebook.com/USHeartVascular

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about US Heart & Vascular